课题基金 / 基金详情

Elucidation for anti-apoptotic action of tetrahydrobiopterin in osteoblastic cells

Elucidation for anti-apoptotic action of tetrahydrobiopterin in osteoblastic cells
阐明四氢生物蝶呤在成骨细胞中的抗凋亡作用
批准号:
10671758
负责人:
MOGI Makio
金额:
$2.56万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

MOGI Makio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We investigated the effects of 5, 6, 7, 8-tetrahydrobiopterin (BH4), a cofactor for nitric oxide (NO) synthase, on NO toxicity in mouse osteoblastic cell line MC3T3-E1 cells. 1) Proinflammatory cytokine mixture (TNF-α, IL-1β, and IFN-γ) and SNAP, an NO generator, decreased cell viability, but sepiapterin, which was converted intracellularly to BH4, increased it. Flow cytometric analysis showed that the reduction of cell viability by cytokines may be based upon cell death by apoptosis, but not lytic death as in necrosis. 2) Cytokine treatment caused the production of BH4. 3) In the presence of BH4, cytokines resulted in a statistically pronounced reduction (*p<0.05) in the amount of DNA fragmentation. These results suggest that the apoptotic cell death in response to cytokines is ascribed to NO and is protective by BH4. BH4 may act as the counterpart and counterbalance to NO-toxicity in MC3T3-E1 cells. 4) Actinobacillus actinomycetemcomitans (AA) has been implicated in the etiology of localized juvenile periodontitis (LJP) and the capsular-like polysaccharide antigen (CPA) from AA, is a potent mediator of bone resorption. CPA contains a potent antiproliferative polysaccharide whose activity is associated with apoptotic cell death in mouse MC3T3-E1 and human osteosarcoma, suggesting that apoptotic cell death in osteoblastic cells is associated with the pathogenesis of LJP. The elucidation of apoptotic mechanism may provide the therapeutic potential information for LJP.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Mogi, M., et al: "Involvement of NO and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse MC3T3-E1"Biochem. Pharmacol.. 58. 649-654 (1999)
Mogi, M. 等人:“NO 和生物蝶呤参与促炎细胞因子诱导的小鼠 MC3T3-E1 细胞凋亡”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto,S., et al.: "Anti-proliferative capsuar-like polysaccharide antigen from actinobacillus actinomycetemcomitans induces apoptotic cell death in mouse osteoblastic MC3T3-E1 cell" Journal of Dental Research. in press (1999)
Yamamoto,S. 等人:“来自放线杆菌放线菌伴生的抗增殖荚膜样多糖抗原诱导小鼠成骨细胞 MC3T3-E1 细胞凋亡”《牙科研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mogi,M.,et al: "Involvement of NO and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse MC3T3-E1."Biochem.Plarmacol.. 58. 649-654 (1999)
Mogi,M.,et al:“NO 和生物蝶呤参与促炎细胞因子诱导的小鼠 MC3T3-E1 细胞凋亡。”Biochem.Plarmacol.. 58. 649-654 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    Physiological significance of RANKL on the pathogenetic mechanism in Periodontitis-related disease : Molecular Pharmacological Research
    • 批准号:
      18592052
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.53万
    • 财政年份:
      2006
    • 负责人:
      MOGI Makio
    • 依托单位:
    Molecular Parmacological Research for TNF-α receptor family on the pathogenetic mechanism in Periodontitis-related disease
    • 批准号:
      15591986
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2003
    • 负责人:
      MOGI Makio
    • 依托单位:
    Elucidation for inflammatory cytokines-induced apoptosis in osteoblastic cells
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: